Phenergan 50 mg injection
As an adjunct to premedication, the suggested dose is 1. In pediatric patients who are acutely ill associated with dehydration, there is an increased susceptibility to dystonias with the use of promethazine hydrochloride injection. Avoid concomitant administration of other drugs with respiratory depressant effects because of an association with respiratory depression, and sometimes death, in pediatric patients. (See also . Promethazine hydrochloride injection should be used cautiously in persons with cardiovascular disease or impairment of liver function. Severe Tissue Injury, Including Gangrene Promethazine hydrochloride injection can cause severe chemical irritation and damage to tissues regardless of the route of administration. 8 how to give phenergan iv ± 3. Idiosyncratic Reaction or Hypersensitivity is there a generic form of provigil Phenergan Injection is contraindicated in patients who have demonstrated an idiosyncratic reaction or hypersensitivity to promethazine or other phenothiazines. Subcutaneous Injection Phenergan Injection should not be given by the subcutaneous route because evidence of chemical irritation has been noted, and necrotic lesions have resulted following subcutaneous injection. The concomitant use of alcohol, sedative/hypnotics (including barbiturates), general anesthetics, narcotics, narcotic analgesics, tricyclic antidepressants, and tranquilizers may phenergan 50 mg injection enhance impairment (see WARNINGS - CNS Depressio n and PRECAUTIONS - Drug Interactions). The mean plasma half-life for promethazine after intramuscular administration in healthy volunteers has been reported phenergan suppository side effects to be 9. Adverse Reactions Respiratory Depression Phenergan Injection is contraindicated in pediatric patients less than 2 years of age, because of the potential for fatal respiratory depression. Aspiration of dark blood does not preclude intra-arterial needle placement because blood is discolored upon contact with PHENERGAN Injection. Sedation In hospitalized adult patients, nighttime sedation may be achieved by a dose of 25 to 50 mg of promethazine hydrochloride injection. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. There are no adequate and well-controlled studies of promethazine hydrochloride injection in pregnant women. • Under no circumstances should PHENERGAN Injection be given by intra-arterial injection due to the likelihood of severe arteriospasm and the possibility of resultant gangrene (see ). ) Nursing Mothers It is cephalon provigil assistance program not known whether does phenergan help with motion sickness Phenergan Injection is excreted in human milk. In pediatric patients who are acutely ill associated with dehydration, there is an increased susceptibility to dystonias with the use of PHENERGAN Injection. A paradoxical-type reaction has been reported phenergan with codeine dosage pediatric in pediatric patients receiving single doses of 75 mg to 125 mg orally, characterized by hyperexcitability and desyrel xanax nightmares. Adverse reactions include burning, pain, erythema, swelling, sensory loss, palsies, paralysis, severe spasm of distal vessels, thrombophlebitis, venous thrombosis, phlebitis, abscesses, tissue necrosis, and gangrene. 4 hours. • For other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. Hallucinations and convulsions have occurred with therapeutic doses and overdoses of PHENERGAN Injection in pediatric patients. Atropine-like signs and symptoms-dry mouth; fixed, dilated pupils; flushing; etc. 1 mg per kg of body weight in combination with an appropriately reduced dose of narcotic or barbiturate and the appropriate dose of an atropine-like drug (see ). Pediatric Use Phenergan Injection is contraindicated for use in pediatric patients less than 2 years of age, because of the potential for fatal respiratory depression. Structural differences from the neuroleptic phenothiazines result in its relative lack (1 /10 that of chlorpromazine) of dopamine antagonist properties. OVERDOSAGE Signs and symptoms of overdosage range from mild depression of the central nervous system and cardiovascular system to profound hypotension, respiratory depression, unconsciousness and sudden death. phenergan from mexico , as well as gastrointestinal symptoms, may occur. Attention should be given to the reestablishment of adequate respiratory exchange through provision of a patent airway and institution of assisted or controlled ventilation. Neuroleptic Malignant SyndromeA potentially fatal symptom complex sometimes referred to as Neuroleptic Malignant Syndrome (NMS) has been reported in association with promethazine hydrochloride alone or in combination with antipsychotic drugs. • Under no circumstances should PHENERGAN Injection be given by intra-arterial injection due to the likelihood of severe arteriospasm and the possibility of resultant gangrene (see ). Structural differences from the neuroleptic phenothiazines result in its relative lack (1 /10 that of chlorpromazine) of dopamine antagonist properties.